ACADIA PHARMACEUTICALS INC (ACAD) Stock Income Statement
NASDAQ:ACAD • US0042251084
Current stock price
20.41 USD
-0.49 (-2.34%)
Last:
| 2025 (2025-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.07B | -804.00K | -2.44M | -1.24M | 484.10M | |||
| Cost Of Goods | 89.00M | 56.00K | 41.64M | 10.20M | 18.00M | |||
| Gross Profit | 982.51M | -860.00K | 684.80M | 507.10M | 466.10M | |||
| Operating Expenses | 877.70M | 636.00K | 477.00K | 494.30K | 636.60M | |||
| Research and Development | 328.80M | 303.25M | 351.62M | 361.60M | 239.40M | |||
| Selling, General, and Administrative Expenses | 548.89M | 636.00K | 477.00K | 494.30K | 396.00M | |||
| Operating Income | 104.81M | -1.50M | -2.92M | -1.73M | -170.40M | |||
| Interest Income/Expense | 31.72M | -72.00K | -76.00K | 165.80K | 600.00K | |||
| Other Income/Expense | 2.37M | 1.82M | 5.11M | 3.50M | 2.30M | |||
| Non Recurring Items | 0.00 | -714.00K | N/A | N/A | N/A | |||
| Income Before Taxes | 138.90M | -2.28M | -3.00M | -1.57M | -167.50M | |||
| Income Tax | -252.10M | 0.00 | 238.00K | -408.70K | 400.00K | |||
| Net Income | 391.00M | -2.28M | -3.24M | -1.16M | -167.90M | |||
| EBITDA | 116.57M | 14.39M | 2.63M | 297.00K | -167.05M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.30 | -0.01 | -0.43 | -0.20 | -1.05 | |||
| Non GAAP EPS | 2.29 | 0.48 | -0.38 | -0.97 | -1.05 | |||
| Statistics | ||||||||
| Gross Profit Margin | 91.69% | 106.97% | -28008.14% | -40938.08% | 96.28% | |||
| Profit Margin | 36.49% | 283.83% | 132.35% | 93.53% | -34.68% | |||
| Operating Profit Margin | 9.78% | 186.07% | 119.51% | 139.90% | -35.20% | |||
All data in USD